The platform technology developed by Mobile Sense is a key element within the emerging eHealth sector, with potential broader impact for detection and management for cardiac conditions.
Farmington, CT (PRWEB) September 06, 2017
Mobile Sense Technologies, Inc. (Mobile Sense) today announced it has been awarded a Small Business Innovation Research (SBIR) Phase I contract from the National Institutes of Health (NIH) National Heart, Lung & Blood Institute (NHLBI). Cofounded by UConn professor of biomedical engineering Dr. Ki Chon, the startup plans to expand development of its patented wearable technology to detect arrhythmias for use in a broader population.
Mobile Sense is building foundational technology enabling off-the-chest wearables for long-term management of cardiac arrhythmias. The traditional cardiac monitoring market relies on seeing a specialist known as an electrophysiologist (EP) to make a diagnosis. Mobile Sense enables people to do a first pass screen of their vital signs on their own using smart watch technology, with the possibility for long-term use of the monitor on the upper arm as prescribed by a cardiologist.
“We are incredibly excited for this NIH SBIR grant, which is designed to run a clinical study looking at patients with arrhythmias, as well as further optimize our algorithms and approach to embed real time detection on the arm band,” said Justin Chickles, CEO and cofounder of Mobile Sense Technologies.
The clinical study will run at University of Massachusetts Memorial Medical Center by lead investigator Dr. Timothy Fitzgibbons with input from co-inventor and Section Chief, Connected Cardiovascular Healthcare, Dr. David McManus.
Arrhythmias are one of the leading causes of strokes and affect 120 million people worldwide. In the United States, six million people are affected; two million of which are identifiable and symptomatic. Mobile Sense aims to expand diagnosis of patients with arrhythmias that are random onset and/or asymptomatic through long term, non-invasive health monitoring.
“The platform technology developed by Mobile Sense is a key element within the emerging eHealth sector, with potential broader impact for detection and management for cardiac conditions,” stated Mostafa Analoui, PhD, UConn’s executive director of venture development and TIP. “The company also has balanced leadership with scientific and business expertise. This is a critical factor for its success in attracting well-deserved clinical and investment support.”
Mobile Sense is housed at the UConn Technology Incubation Program (TIP) at UConn Health in Farmington, CT.
About Mobile Sense Technologies, Inc.
Mobile Sense is building foundational technology enabling off-the-chest wearables for long term management of cardiac arrhythmias. They are replacing today’s invasive and inconvenient cardiac monitoring technology which includes wires and patches, with simple easy to use, wearable devices. Mobile Sense is led by CEO and Co-Founder, Justin Chickles, a serial entrepreneur and startup veteran and former medical device innovator and leader at Johnson & Johnson. Prof. Ki. Chon, Chair of Biomedical Engineering at the University of Connecticut, is the CTO and Co-Founder of Mobile Sense and developed the technology while at the University of Connecticut, Worcester Polytech Institute, and the State University of New York. Mobile Sense investors include Connecticut Innovations and angel investors. Mobile Sense is in process of raising their Series A - http://www.mobilesensetech.com.
About UConn’s Technology Incubation Program (TIP)
UConn’s Technology Incubation Program (TIP) is the only university-based technology business incubation program in Connecticut. Established in 2004, TIP couples UConn's world-class research resources, facilities, and business support services with a network of experienced investors and entrepreneurs to help launch high-potential startups. Since 2004, the program has helped over 90 companies that have raised more than $50 million in grants and $135 million in equity and debt. https://tip.uconn.edu/
About the NIH SBIR
The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs award federal research grants and contracts to small businesses conducting biomedical research. The purpose of these programs is to commercialize innovative technologies that improve health and save lives. Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R43HL135961. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. https://sbir.nih.gov